TC BioPharm (Holdings) plc

TC Biopharm (holdings) PLC

Biotechnology Healthcare Motherwell, United Kingdom TCBWF (PNK)

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, develops immunotherapy products based on its allogeneic gamma delta T cell platform in the United States. Its product pipeline comprises OmnImmune (TCB002), an allogeneic unmodified gamma-delta T cell therapy product which is in phase 2/3 clinical trial for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections, as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

Stock Performance (90 Days)

Data through Oct 16, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Biotechnology Companies

View All →

Frequently Asked Questions

Has TC BioPharm (Holdings) plc had layoffs?
No layoff events have been recorded for TC BioPharm (Holdings) plc in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does TC BioPharm (Holdings) plc have?
TC BioPharm (Holdings) plc has approximately 39 employees.
What industry is TC BioPharm (Holdings) plc in?
TC BioPharm (Holdings) plc operates in the Biotechnology industry, within the Healthcare sector.
Is TC BioPharm (Holdings) plc a publicly traded company?
Yes, TC BioPharm (Holdings) plc is publicly traded under the ticker symbol TCBWF on the PNK.
Where is TC BioPharm (Holdings) plc headquartered?
TC BioPharm (Holdings) plc is headquartered in Motherwell, United Kingdom at Maxim 1, United Kingdom.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.